Person: DİZMAN, DİDEM
15 results
Search Results
Now showing 1 - 10 of 15
Publication Metadata only Treatment profile of patients with moderate-to-severe psoriasis included in the Turkish national registry PSR-TR(2017-11-01) Onsun, NAHİDE; Baskan, E. B.; DIZMAN, DİDEM; OZKAYA, D. B.; Erkilic, A. C.; Ozarmagan, G.; Gurer, M. A.; ONSUN, NAHIDE; DİZMAN, DİDEMPublication Metadata only Localized Darier-s Disease(2016-08-01) BAHALI, Anil G.; Su, Ozlem; Biyik Ozkaya, DİLEK; Dizman, DİDEM; Yildiz, PELİN; Demirkesen, Cuyan; Onsun, NAHİDE; BAHALI, ANIL GÜLSEL; SU KÜÇÜK, ÖZLEM; BIYIK ÖZKAYA, DİLEK; DİZMAN, DİDEM; YILDIZ, PELİN; ONSUN, NAHIDEPublication Metadata only Correlation of clinical, dermoscopical and histopathological features of all subtypes of basal cell carcinoma(2017-06-01) DIZMAN, DİDEM; OZKAYA, D. B.; BAHALI, A. G.; DIZMAN, B. T.; YILDIZ, PELİN; TOSUNER, ZEYNEP; Demirkesen, C.; ONSUN, NAHİDE; SU, O.; DİZMAN, DİDEM; YILDIZ, PELİN; TOSUNER, ZEYNEP; SU KÜÇÜK, ÖZLEM; ONSUN, NAHIDEPublication Metadata only Non-dipping nocturnal blood pressure in psoriasis vulgaris.(2012-12-01) BACAKSIZ, AHMET; Akif, Vatankulu; SONMEZ, O; ERDOGAN, EZGİ BAŞAK; TASAL, A; TURFAN, M; ERTAS, G; SEVGILI, E; Dizman, DİDEM; ONSUN, NAHİDE; BACAKSIZ, AHMET; DİZMAN, DİDEM; ONSUN, NAHIDEPublication Metadata only Bullous pemphigoid during ustekinumab therapy in a psoriatic patient(2017-01-01) Onsun, NAHİDE; SALLAHOGLU, Kadriye; Su, Ozlem; Tosuner, ZEYNEP; ONSUN, NAHIDE; DİZMAN, DİDEM; SU KÜÇÜK, ÖZLEM; TOSUNER, ZEYNEPPublication Metadata only Isolated interdigital Kaposi sarcom in HIV negative patient(2016-12-01) BAHALI, Amil G.; Su, Ozlem; BIYIK OZKAYA, Duck; Dizman, DİDEM; Tosuner, ZEYNEP; Demirkesen, Cuyan; Onsun, NAHİDE; SU KÜÇÜK, ÖZLEM; DİZMAN, DİDEM; TOSUNER, ZEYNEP; ONSUN, NAHIDEPublication Metadata only Treatment of localized pagetoid reticulosis with imiquimod: a case report and literature review(2016-02-01) Su, O.; DIZMAN, DİDEM; ONSUN, NAHİDE; BAHALI, A. G.; OZKAYA, D. Biyik; TOSUNER, ZEYNEP; Demirkesen, C.; SU KÜÇÜK, ÖZLEM; DİZMAN, DİDEM; ONSUN, NAHIDE; TOSUNER, ZEYNEPPublication Metadata only A multicentre prospective analysis of the incidence of pemphigoid diseases in Turkey(2021-10-01T00:00:00Z) DURDU, MURAT; Bozca, Burcin Cansu; ENLİ, SERVİNAZ; Yazici Ozgen, Zuleyha; YAYLI, SAVAŞ; AKTAN, ŞEBNEM; MUTLU, DERYA; ERTURAN, İjlal; AYVAZ ÇELİK, Havva Hilal; MELİKOĞLU, Mehmet; PALA, Erdal; Gursel Urun, Yildiz; HARMAN, MEHMET; BOZKURT ŞAVK, EKİN; Isik, Selin; Duygulu, Seniz; Imren, Isil Gogem; FETTAHLIOĞLU KARAMAN, BİLGE; KAYA ERDOĞAN, HİLAL; KILIÇ, ARZU; Ozcelik, Sinan; Inan, Kiymet; Yilmaz, Mustafa Anil; Sanli, Hatice Erdi; Kalay Yildizhan, Incilay; MÜLAYİM, MEHMET KAMİL; Cicek, Demet; Demir, Betul; YASAK GÜNER, RUKİYE; BAYKAL SELÇUK, LEYLA; GÜNDÜZ, KAMER; DAYE, MUNİSE; BORLU, MURAT; ÖKSÜM SOLAK, EDA; DİZMAN, DİDEM; GÜNEŞ, BEGÜM; Ozkur, Ezgi; Polat, Mualla; Eskiocak, Ali Haydar; UZUN, SONER; DİZMAN, DİDEM; GÜNEŞ, BEGÜMBackground The differentiation between the pemphigoid diseases is essential for treatment and prognosis. In Turkey, data on the incidence of these diseases are insufficient. Our aim in this study is to determine the incidence, demographics and clinical characteristics associated with diseases of the pemphigoid group. Methods We prospectively analysed 295 patients with pemphigoid who visited dermatology clinics of tertiary referral hospitals in 12 different regions of Turkey within a year. The diagnosis was based on clinical, histopathological, direct immunofluorescence (DIF) and serological (multivariant enzyme-linked immunosorbent assay [ELISA], indirect immunofluorescence and mosaic-based BIOCHIP) examinations. Clinical and demographic findings, aetiological factors and concomitant diseases observed in the patients were recorded. Results A total of 295 (female/male ratio: 1.7/1) patients with pemphigoid were diagnosed in 1-year period. The overall incidence rate of pemphigoid diseases was found to be 3.55 cases per million-years. The ratio of pemphigoid group diseases to pemphigus group diseases was 1.6. The most common pemphigoid type was bullous pemphigoid (BP, 93.2%). The others were epidermolysis bullosa acquisita (3.1%), pemphigoid gestationis (2.4%), linear IgA disease (1%) and mucous membrane pemphigoid (0.3%). The most common (26.8%) possible trigger of the bullous pemphigoid was gliptin derivative drugs. The most common concomitant diseases with pemphigoid were cardiovascular (27.8%) and neurological diseases (23.7%). Conclusions This study showed that the increased frequency of bullous pemphigoid reversed the pemphigoid/pemphigus ratio in Turkey. Further studies are warranted regarding the reasons for this increase.Publication Metadata only Solitary Eccrine Syringofibroadenoma and Successful Treatment with Cryotherapy(2016-05-01) OZKAYA, Dilek Biyik; Su, Ozlem; Bahali, ANIL GÜLSEL; TOPUKCU, Bugce; Dizman, DİDEM; Tosuner, ZEYNEP; Demirkesen, Cuyan; Onsun, NAHİDE; SU KÜÇÜK, ÖZLEM; BAHALI, ANIL GÜLSEL; DİZMAN, DİDEM; TOSUNER, ZEYNEP; ONSUN, NAHIDEFirst described in 1963, eccrine syringofibroadenoma (ESFA) is a rare benign tumor that proliferates with differentiation toward ductal eccrine structures. There are many clinical presentations, including plaques, papules, verrucous plaques, keratotic tumors, and solitary tumors. The age of onset varies, with presentation between 16 and 80 years; however, solitary lesions are seen most commonly in the seventh and eighth decades. Here, we present the case of a 72-year-old woman referred to our outpatient clinic with a nodule on her leg. The histopathology result was ESFA. The lesion regressed after six cryotherapy sessions. Physicians should consider the possibility of ESFA and must remember its malignant potential in elderly patients.Publication Metadata only Association of Pre-miRNA-499 rs3746444 and Pre-miRNA-146a rs2910164 Polymorphisms and Susceptibility to Behcet-s Disease.(2015-08-01T00:00:00Z) ONER, T; YENMIS, G; TOMBULTURK, K; CAM, C; Kucuk, OS; YAKICIER, MC; DIZMAN, DİDEM; SULTUYBEK, GK; SU KÜÇÜK, ÖZLEM; DİZMAN, DİDEM